Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-23

Clinical Trial Update: Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

View source ↗

Summary

A completed real-world study evaluating the effectiveness and safety of ranibizumab in patients with wet age-related macular degeneration, diabetic macular edem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranibizumab (ranibizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Wet Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Wet Age Related Macular Degeneration | Status: COMPLETED